144 related articles for article (PubMed ID: 2052517)
1. Prodrugs of peptides. 9. Bioreversible N-alpha-hydroxyalkylation of the peptide bond to effect protection against carboxypeptidase or other proteolytic enzymes.
Bundgaard H; Rasmussen GJ
Pharm Res; 1991 Mar; 8(3):313-22. PubMed ID: 2052517
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs of peptides. 13. Stabilization of peptide amides against alpha-chymotrypsin by the prodrug approach.
Kahns AH; Bundgaard H
Pharm Res; 1991 Dec; 8(12):1533-8. PubMed ID: 1808620
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.
Bundgaard H; Møss J
Pharm Res; 1990 Sep; 7(9):885-92. PubMed ID: 2122435
[TBL] [Abstract][Full Text] [Related]
4. Transpeptidase activity of Streptomyces D-alanyl-D carboxypeptidases.
Pollock JJ; Ghuysen JM; Linder R; Salton MR; Perkins HR; Nieto M; Leyh-Bouille M; Frere JM; Johnson K
Proc Natl Acad Sci U S A; 1972 Mar; 69(3):662-6. PubMed ID: 4501580
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs of peptides. 11. Chemical and enzymatic hydrolysis kinetics of N-acyloxymethyl derivatives of a peptide-like bond.
Bundgaard H; Rasmussen GJ
Pharm Res; 1991 Oct; 8(10):1238-42. PubMed ID: 1796040
[TBL] [Abstract][Full Text] [Related]
6. Prodrugs of peptides. IV: Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase.
Bundgaard H; Møss J
J Pharm Sci; 1989 Feb; 78(2):122-6. PubMed ID: 2565975
[TBL] [Abstract][Full Text] [Related]
7. Structure and dynamics of the metal site of cadmium-substituted carboxypeptidase A in solution and crystalline states and under steady-state peptide hydrolysis.
Bauer R; Danielsen E; Hemmingsen L; Sorensen MV; Ulstrup J; Friis EP; Auld DS; Bjerrum MJ
Biochemistry; 1997 Sep; 36(38):11514-24. PubMed ID: 9298972
[TBL] [Abstract][Full Text] [Related]
8. Carboxypeptidase-mediated release of methotrexate from methotrexate alpha-peptides.
Kuefner U; Lohrmann U; Montejano YD; Vitols KS; Huennekens FM
Biochemistry; 1989 Mar; 28(5):2288-97. PubMed ID: 2719954
[TBL] [Abstract][Full Text] [Related]
9. Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.
Liederer BM; Borchardt RT
J Pharm Sci; 2005 Oct; 94(10):2198-206. PubMed ID: 16136552
[TBL] [Abstract][Full Text] [Related]
10. Prodrugs of peptides. 19. Protection of the pyroglutamyl residue against pyroglutamyl aminopeptidase by N-acyloxymethylation and other means.
Møss J; Bundgaard H
Acta Pharm Nord; 1992; 4(4):301-8. PubMed ID: 1363462
[TBL] [Abstract][Full Text] [Related]
11. Amino acid side chain induced selectivity in the hydrolysis of peptides catalyzed by a Zr(IV)-substituted Wells-Dawson type polyoxometalate.
Vanhaecht S; Absillis G; Parac-Vogt TN
Dalton Trans; 2013 Nov; 42(43):15437-46. PubMed ID: 24018583
[TBL] [Abstract][Full Text] [Related]
12. Bioreversible quaternary N-acyloxymethyl derivatives of the tertiary amines bupivacaine and lidocaine--synthesis, aqueous solubility and stability in buffer, human plasma and simulated intestinal fluid.
Nielsen AB; Buur A; Larsen C
Eur J Pharm Sci; 2005 Apr; 24(5):433-40. PubMed ID: 15784333
[TBL] [Abstract][Full Text] [Related]
13. Palladium(II) complex as a sequence-specific peptidase: hydrolytic cleavage under mild conditions of X-Pro peptide bonds in X-Pro-Met and X-Pro-His segments.
Milović NM; Kostić NM
J Am Chem Soc; 2003 Jan; 125(3):781-8. PubMed ID: 12526679
[TBL] [Abstract][Full Text] [Related]
14. Effect of modifiers on the hydrolysis of basic and neutral peptides by carboxypeptidase B1.
Moore GJ; Benoiton NL
Can J Biochem; 1975 Jul; 53(7):747-57. PubMed ID: 1170927
[TBL] [Abstract][Full Text] [Related]
15. Effect of Nepsilon-alkylation of the substrate on the hydrolysis of benzoylglycyl-L-lysine by carboxypeptidase B1.
Moore GJ; Benoiton NL
Can J Biochem; 1975 Nov; 53(11):1145-9. PubMed ID: 1238154
[TBL] [Abstract][Full Text] [Related]
16. Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability.
Gudmundsson OS; Pauletti GM; Wang W; Shan D; Zhang H; Wang B; Borchardt RT
Pharm Res; 1999 Jan; 16(1):7-15. PubMed ID: 9950272
[TBL] [Abstract][Full Text] [Related]
17. Action of serine carboxypeptidases on endopeptidase substrates, peptide-4-methyl-coumaryl-7-amides.
Kunugi S; Fukuda M; Hayashi R
Eur J Biochem; 1985 Nov; 153(1):37-40. PubMed ID: 3905405
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic digestibility of peptides cross-linked by ionizing radiation.
Dizdaroglu M; Gajewski E; Simic MG
Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Mar; 45(3):283-95. PubMed ID: 6143737
[TBL] [Abstract][Full Text] [Related]
19. A thioamide substrate of carboxypeptidase A.
Bartlett PA; Spear KL; Jacobsen NE
Biochemistry; 1982 Mar; 21(7):1608-11. PubMed ID: 7082637
[TBL] [Abstract][Full Text] [Related]
20. Hydrolysis of peptides by carboxypeptidase A: equilibrium trapping of the ES2 intermediate.
Geoghegan KF; Galdes A; Hanson G; Holmquist B; Auld DS; Vallee BL
Biochemistry; 1986 Aug; 25(16):4669-74. PubMed ID: 3021197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
